Cyclooxygenase blockade attenuates responses of group III and IV muscle afferents to dynamic exercise in cats.
Cyclooxygenase products accumulate in statically contracting muscles to stimulate group III and IV afferents. The role played by these products in stimulating thin fiber muscle afferents during dynamic exercise is unknown. Therefore, in decerebrated cats, we recorded the responses of 17 group III and 12 group IV triceps surae muscle afferents to dynamic exercise, evoked by stimulation of the mesencephalic locomotor region. Each afferent was tested while the muscles were freely perfused and while the circulation to the muscles was occluded. The increases in group III and IV afferent activity during dynamic exercise while the circulation to the muscles was occluded were greater than those during exercise while the muscles were freely perfused (P < 0.01). Indomethacin (5 mg/kg iv), a cyclooxygenase blocker, reduced the responses to dynamic exercise of the group III afferents by 42% when the circulation to the triceps surae muscles was occluded (P < 0.001) and by 29% when the circulation was not occluded (P = 0.004). Likewise, indomethacin reduced the responses to dynamic exercise of group IV afferents by 34% when the circulation was occluded (P < 0.001) and by 18% when the circulation was not occluded (P = 0.026). Before indomethacin, the activity of the group IV, but not group III, afferents was significantly higher during postexercise circulatory occlusion than during rest (P < 0.05). After indomethacin, however, group IV activity during postexercise circulatory occlusion was not significantly different from group IV activity during rest. Our data suggest that cyclooxygenase products play a role both in sensitizing group III and IV afferents during exercise and in stimulating group IV afferents during postexercise circulatory occlusion.
Hayes
Shawn G
SG
Division of Cardiovascular Medicine, Univ. of California-Davis, CA 95616, USA. sghayes@ucdavis.edu
Kindig
Angela E
AE
Kaufman
Marc P
MP
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism; D002415:Cats; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D004576:Electromyography; D006614:Hindlimb / Q000098:blood supply; D007213:Indomethacin / Q000494:pharmacology; D008124:Locomotion / Q000502:physiology; D008636:Mesencephalon / Q000502:physiology; D009119:Muscle Contraction / Q000502:physiology; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000294:innervation*; D009475:Neurons, Afferent / Q000187:drug effects*; D005082:Physical Exertion / Q000502:physiology*; D012039:Regional Blood Flow / Q000502:physiology
D016861:Cyclooxygenase Inhibitors; D016718:Arachidonic Acid; D007213:Indomethacin